|
|
||||||||
1 National Institute of Animal Health, Tsukuba, Ibaraki 305-0856, Japan
2 Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
3 School of Veterinary Medicine and Animal Sciences, Kitasato University, Towada, Aomori 034-8628, Japan
4 United Graduate School of Veterinary Sciences, Gifu University, Gifu 501-1193, Japan
Correspondence
Tsutomu Sekizaki
sekizaki{at}affrc.go.jp
Received 8 November 2007
Accepted 5 December 2007
Abbreviations: EF, extracellular factor; MLST, multilocus sequence typing; MRP, muramidase-released protein; OFS, opacity factor of Streptococcus suis; SOF, serum opacity factor of Streptococcus pyogenes; ST, sequence type.
The GenBank/EMBL/DDBJ accession numbers for the sequences of the ofs loci of S. suis NIAH 11433, DAT299, DAT246, DAT252 and MNCM51 are AB325706, AB325707, AB325708, AB325709 and AB325710, respectively, and for the new allele sequences of aroA, cpn60, dpr, gki, mutS, recA and thrA are AB330897–AB330899, AB330900–AB330907, AB330908–AB330909, AB330910–AB330915, AB330916–AB330922, AB330923–AB330927 and AB330928–AB330932, respectively.
A table of isolates and a figure showing Southern blot hybridization analysis are available as supplementary material with the online version of this paper.
| INTRODUCTION |
|---|
|
|
|---|
Despite increasing research in recent years, knowledge of the virulence determinants of S. suis remains limited. The polysaccharide capsule of S. suis serotype 2 is proven to be one of the major virulence determinants (Smith et al., 1999). However, not all encapsulated serotype 2 strains are virulent and there is variation in the degrees of virulence among the strains (Vecht et al., 1989, 1992). Published studies have also reported several putative virulence factors, including the muramidase-released protein (MRP), the extracellular factor (EF) and suilysin (Jacobs et al., 1994; Vecht et al., 1991). In contrast to MRP– EF– serotype 2 strains from Europe, serotype 2 strains expressing the 136 kDa MRP and the 110 kDa EF were highly virulent (Vecht et al., 1991, 1992). Therefore, these factors were thought to contribute to the pathogenesis of S. suis. However, because many virulent isolates lacking these factors have also been isolated from clinical cases in North America (Gottschalk et al., 1998), the significance of these factors in the pathogenesis of S. suis is still unclear.
Recently, a serum opacity factor of S. suis (OFS) has been identified as a novel virulence determinant of S. suis serotype 2 (Baums et al., 2006). This protein has the typical structural features of Gram-positive surface proteins, which consist of a putative N-terminal signal sequence, a large N-terminal domain, repetitive sequence elements and a C-terminal LPXTG anchor motif (Baums et al., 2006). Particularly, the N-terminal domain is homologous to the corresponding region of the serum opacity factor of Streptococcus pyogenes (SOF), and the domain has been shown to have serum opacification activity (Baums et al., 2006). Disruption of ofs resulted in a severe attenuation of virulence when investigated in porcine experimental models, suggesting the significance of OFS in the pathogenesis of S. suis (Baums et al., 2006). However, it is unknown whether this factor is widely present among S. suis strains, as only one strain was used for the reported study.
In this study, we investigated the prevalence of the ofs gene using 108 S. suis isolates from diseased pigs, healthy pigs and human patients. Our results showed that there were at least four distinct ofs genotypes in S. suis, and one of the genotypes was strongly associated with isolates of a genetically clonal group that is frequently isolated from pigs and humans with invasive disease throughout the world.
| METHODS |
|---|
|
|
|---|
DNA methods.
S. suis chromosomal DNA was extracted as described previously (Osaki et al., 2000). Ex Taq polymerase (Takara Bio) was used for PCR amplifications. For PCR-based screening of the ofs gene, primers Ofs-F (5'-GATGTGACTGTCCGCAGAGC-3') and Ofs-R2 (5'-AAAGTACCTGAGCTCCTACA-3') were used to amplify the internal segment of ofs (Fig. 1a
), and reaction mixtures were prepared according to the manufacturer's instructions, except that the concentration of MgCl2 used was 2.5 mM. The program for the amplification consisted of an initial denaturation of 2 min at 96 °C, 30 cycles of 20 s at 96 °C, 10 s at 55 °C and 1 min at 72 °C, and a final extension of 1 min at 72 °C. Southern blot hybridization was performed as described previously (Sekizaki et al., 2001) with a DIG (digoxigenin) DNA labelling and detection kit (Roche). Prehybridization and hybridization were carried out at 65 °C for 2 and 16 h, respectively. For preparation of the ofs probe, an internal fragment of ofs was amplified from the genomic DNA of NIAH 11433 using primers Ofs-pr1 (5'-AAATAAGGAAGGAGAGGTGG-3') and Ofs-pr2 (5'-ACAAGAAGAGAGAGGGCAGT-3'), and labelled with DIG by using the DIG DNA labelling and detection kit. Sequencing of various PCR products was carried out with a BigDye terminator v3.1 cycle sequencing kit using a 3100 Genetic Analyzer (Applied Biosystems).
|
For sequence determination of the ofs regions of NIAH 11433, MNCM51, DAT246, DAT252 and DAT299, PCR products amplified by primers Ofs-F and Ofs-R2 were sequenced by primer walking, and BLAST searches (http://www.ncbi.nlm.nih.gov/BLAST) were performed using the determined sequences. Because the sequence of the PCR product of NIAH 11433 was identical to that of the corresponding ofs region of S. suis strain 10, primers Ofs-AF (5'-ACTTCTTCGATTACACGTCC-3') and Ofs-AR (5'-CCATCACTATTATAGGCATAATCTC-3') were constructed on the basis of the sequence of strain 10 ofs. The whole ofs gene of NIAH 11433 was amplified, and the resultant 2.95 kb PCR product was sequenced by primer walking. For further sequencing of the upstream region of the ofs locus of NIAH 11433, an additional primer, Ofs-sq7 (5'-GAAAATACCTAAAGAAGGGCG-3'), was designed from the upstream sequence of the strain 10 ofs. The chromosomal region containing the upstream region of the ofs locus of NIAH 11433 was amplified with primers Ofs-sq7 and Ofs-R2, and the resultant PCR product was sequenced with primer Ofs-sq7.
Because BLAST searches showed that the sequence of the PCR product of MNCM51 was almost identical to those of the corresponding ofs regions of strain 89/1591, the whole ofs gene of MNCM51 was amplified with primers Ofs-AF2 (5'-TCCCAAAAGCTCTACGCTTC-3') and Ofs-AR2 (5'-TTCAGCCTCTGCAGCTATTG-3'), which were designed from the ofs sequences of strain 89/1591. The resultant 5.0 kb PCR product was then sequenced by primer walking.
For sequencing the ofs regions of DAT246, DAT252 and DAT299, primers Ofs-IV1 (5'-ATGTAGACTCCCCTTGTGAC-3') and Ofs-IV2 (5'-GATTCAGATAACTCTGCTCC-3') were designed for inverse PCR on the basis of the sequences of the PCR products amplified by primers Ofs-F and Ofs-R2. DNA fragments of about 11.0, 9.0 and 9.0 kb were amplified with primers Ofs-IV1 and Ofs-IV2 from PstI-digested and self-ligated genomic DNA of DAT246 and DAT252, and StuI-digested and self-ligated genomic DNA of DAT299, respectively. The products were then sequenced by primer walking. Signal sequences of the OFS proteins deduced from the determined sequences were predicted by the SignalP program (http://www.cbs.dtu.dk/services/SignalP).
Detection of serum opacification activity. The 1 % SDS extraction technique, which has been described elsewhere (Baums et al., 2006), was used with the following modifications. A 1 ml aliquot of mid-exponential phase culture (OD600=0.3–0.4) was inoculated into 40 ml fresh THY broth. After 4 h of growth at 37 °C, 160 µl protease inhibitor cocktail (Sigma) was added to the cultures. Incubation at 37 °C was continued for an additional 2 h, and the bacterial cells were collected by centrifugation. The pellet was resuspended in 300 µl prewarmed (42 °C) 1 % SDS and rotated end-over-end at 37 °C for 1 h. For the detection of serum opacification activity of secreted proteins, the culture supernatants were filtered with a Millex-GV sterilizing filter unit with a 0.22 µm pore size (Millipore) and placed on ice until use. A 25 µl aliquot of the SDS extract or the filtered culture supernatant was added to 100 µl horse serum (Sigma) in the wells of 96-well plates and mixed. As negative controls, 1 % SDS or THY broth was added to the respective wells. The sealed plates were incubated with moderate shaking at 37 °C for 40 h. After the addition of 100 µl 0.9 % NaCl, the A450 value was measured. Differences in serum opacification activity were compared by unpaired t-test using Welch's modification.
Multilocus sequence typing (MLST). MLST was performed by sequencing seven housekeeping genes as described by King et al. (2002). The allelic numbers and sequence types (STs) of the isolates were determined by comparing their sequences with those in the S. suis MLST database (http://ssuis.mlst.net). Novel alleles and STs were assigned through submission of the respective data to the database. Analysis of ST complexes was performed with the eBURST program (http://eburst.mlst.net) (Feil et al., 2004).
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
As shown in Fig. 2
, the sequence analysis identified several allelic variants of ofs. The ofs gene of NIAH 11433 (designated type-1 ofs) was 2817 bp in length, and the nucleotide sequence was completely identical to that of strain 10 (Baums et al., 2006). The ofs variant of DAT299 (designated type-2 ofs) was 3177 bp in length and encoded a protein of 1058 amino acids. Similar to type-1 OFS, type-2 OFS also consisted of a signal sequence, a large N-terminal domain, repetitive sequence elements and a C-terminal cell wall sorting signal (Fig. 2
). The deduced amino acid sequence of type-2 OFS was 79.0 % identical and 84.9 % similar to that of type-1 OFS. However, due to mutations, the position of the start codon of type-2 ofs was different from that of type-1 ofs, resulting in alteration of the signal sequence (Fig. 3
). In addition, type-1 OFS possessed three repetitive sequence elements, while type-2 OFS possessed four repetitive sequence elements (Fig. 2
).
|
|
In MNCM51, the ofs gene was disrupted by the insertion of an IS element. The gene (designated type 4) was supposed to produce a protein of 564 amino acids (Fig. 2
), and the deduced amino acid sequence was 70.3 and 84.6 % identical to those of type-1 and type-2 OFS, respectively. Strain 89/1591 also has a similar gene whose nucleotide sequence was completely identical to that of type-4 ofs of MNCM51. However, in 89/1591, the genetic region was separated by an IS element and was translocated (Fig. 2
).
These results demonstrated that in S. suis there are at least three allelic variants of ofs in addition to the originally reported ofs gene. However, because type-3 and type-4 ofs were interrupted by mutations, only type-1 and type-2 ofs seem to produce intact OFS proteins. We hereafter refer to the isolates that produced PCR fragments of 1.96, 2.1 and 3.3 kb with primers Ofs-F and Ofs-R2 as isolates with type-1, type-2 and type-4 ofs, respectively. The isolates that generated PCR products of either 1.6 or 1.8 kb are referred to as isolates with type-3 ofs. In addition, the isolates that did not produce any specific PCR products were further analysed by Southern blot hybridization analysis. Using ClaI-digested genomic DNA and the ofs probe prepared from type-1 ofs, they were classified as ofs-negative isolates and isolates with type-4 ofs (see Supplementary Fig. S1 and Supplementary Table S1 available with the online journal).
Serum opacification activity of OFS and its variants
SDS extracts and culture supernatants of eight representative isolates were tested for their ability to opacify a serum. As speculated from the sequence data, only the isolates with type-1 ofs and type-2 ofs showed surface-associated serum opacification activity (Fig. 4a
). The opacification activities of the isolates were significantly higher (P<0.05) than those of the isolates with type-3 ofs or type-4 ofs, indicating that only type-1 and type-2 ofs can express functional OFS on the cell surface.
|
In S. pyogenes, expression of sof is positively regulated by the multiple-gene regulator Mga (formerly designated VirR), which also co-regulates the expression of emm, encoding M protein, and scpA, encoding the C5a peptidase (Podbielski et al., 1992; McLandsborough & Cleary, 1995). However, it is unknown how S. suis regulates the expression of ofs. Intriguingly, even though the deduced amino acid sequences of type-1 OFS in P1/7 and NIAH 11433 are identical to each other (D. Takamatsu, M. Osaki & T. Sekizaki, data not shown), the serum opacification activity of the SDS extract of P1/7 was significantly lower than that of NIAH 11433 (P=0.0280) (Fig. 4a
). Although the difference in the serum opacification activities could be caused by differences in the extraction efficiency of surface-associated proteins between the two strains, S. suis may have some regulatory mechanisms for the expression of ofs.
Correlation of the ofs genotypes with MLST results
As shown in Table 1
, regardless of their origin, approximately 30 % of the isolates tested possessed either type-1 or type-2 ofs. However, isolates with type-2 ofs were recovered only from three healthy pigs. By means of MLST analysis using representative isolates, a strong association between the ST1 complex and isolates with type-1 ofs was observed. In addition, the majority of isolates with type-3 ofs and type-4 ofs were assigned to the ST27 complex. On the other hand, isolates with type-2 ofs were not related to known ST complexes (Table 2
).
|
|
In our previous report, we superimposed the distribution of the virulence-associated genes mrp (encoding MRP), epf (encoding EF) and sly (encoding suilysin) on the MLST data, and found that all the isolates assigned to the ST1 complex were positive for mrp (or its variant), epf (or its variant) and sly. However, the isolates assigned to the ST27 complex did not possess one or more of these genes (Takamatsu et al., 2008). Similar data were also reported by Rehm et al. (2007). Among the isolates they analysed, all the isolates assigned to ST1 were positive for mrp, epf and sly, while the other isolates, except for one, lacked one or more of these genes. These results suggest that mrp, epf and sly can be used as epidemiological markers for ST1 complex members. However, because mrp, epf or sly mutants have been shown to be as virulent as the respective wild-type strains after experimental infection of newborn or young pigs (Smith et al., 1996; Lun et al., 2003), it is unclear whether or not these markers have some role in the pathogenesis of the ST1 complex members. On the contrary, severe attenuation in virulence of an ofs mutant was demonstrated by an experimental infection model in piglets, and ofs was suggested to be an important virulence determinant (Baums et al., 2006). These results, together with the present findings, suggest that type-1 OFS is one of the important virulence factors that may confer upon the ST1 complex members an ability to cause invasive diseases.
SOF of S. pyogenes has been established as a virulence determinant (Courtney et al., 1999). Disruption of high-density lipoprotein (HDL), which is an anti-inflammatory and anti-atherogenic factor, by SOF is suggested to contribute to the pathogenesis of S. pyogenes infection (Courtney et al., 2006). Although it is unknown how OFS is involved in the pathogenesis of S. suis, a similar mechanism may contribute to the development of invasive diseases by this organism. However, in our data, approximately 70 % of the S. suis isolates from diseased pigs and human patients did not possess functional ofs genes (Table 1
). In addition, genes encoding type-2 OFS showing higher opacification activities than type-1 OFS were found only in isolates from healthy pigs. These results indicate that OFS is not an essential nor a sufficient factor for S. suis isolates to cause invasive diseases. For further comprehensive understanding of the pathogenesis of S. suis, identification of additional virulence determinants and comparison of their distribution with the MLST dataset will be needed.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |